These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18847424)

  • 1. [Updates in hemodialysis].
    Arenas Jiménez MD
    Nefrologia; 2008; 28 Suppl 5():71-6. PubMed ID: 18847424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malnutrition, inflammation, atherosclerosis in hemodialysis patients.
    Jeznach-Steinhagen A; Słotwiński R; Szczygieł B
    Rocz Panstw Zakl Hig; 2007; 58(1):83-8. PubMed ID: 17711095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
    Pawlaczyk K; Oko A; Lindholm B; Czekalski S
    Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis patients and cardiovascular problems: can technology solve the complex equation?
    Ronco C; Tetta C
    Expert Rev Med Devices; 2005 Nov; 2(6):681-7. PubMed ID: 16293095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protecting the endothelium: a new focus for management of chronic kidney disease.
    Diaz-Buxo JA; Woods HF
    Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?
    Himmelfarb J
    Semin Dial; 2004; 17(6):449-54. PubMed ID: 15660575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New study evaluating online haemodiafiltration for the reduction of cardiovascular morbidity and mortality in patients undergoing chronic haemodialysis].
    Penne EL; Blankestijn PJ; Bots ML; van den Dorpel MA; Grooteman MP; Nubé MJ; ter Wee PM
    Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1583-5. PubMed ID: 16886698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
    Shojaei MH; Djalali M; Siassi F; Khatami MR; Boroumand MA; Eshragian MR
    Iran J Kidney Dis; 2009 Jul; 3(3):141-4. PubMed ID: 19617662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic renal disease as cardiovascular risk factor].
    Hermans MM; Kooman JP; Stehouwer CD
    Ned Tijdschr Geneeskd; 2008 Jul; 152(29):1614-8. PubMed ID: 18998268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oxidative stress analysis in patients on hemodiafiltration on-line].
    Torregrosa E; Hernández Jaras J; Sastre J; Pons R; García Calvo H; Calvo Gordo C; Fenollosa MA; Rius A; Sánchez-Canel JJ; Pin M; Tamarit E; Rico I
    Nefrologia; 2007; 27(5):612-8. PubMed ID: 18045038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Updates in clinical hemodialysis: vascular accessess and elderly patients].
    López Gómez JM
    Nefrologia; 2008; 28 Suppl 5():67-70. PubMed ID: 18847423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines, metalloproteinases, neopterin and cardiovascular mortality among patients with chronic renal failure].
    Kościów K; Małecki R; Adamiec R
    Pol Merkur Lekarski; 2007 Jan; 22(127):54-7. PubMed ID: 17477092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of augmenting dialysis frequency and duration on cardiovascular function.
    Ly J; Chan CT
    ASAIO J; 2006; 52(6):e11-4. PubMed ID: 17117036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
    Catena C; Cavarape A; Dotto L; Colussi G; Novehllo M; De Marchi S; Sechi LA
    Adv Clin Path; 2003 Jan; 7(1):3-11. PubMed ID: 19774732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease.
    Himmelfarb J
    Cardiol Clin; 2005 Aug; 23(3):319-30. PubMed ID: 16084281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study.
    Penne EL; Blankestijn PJ; Bots ML; van den Dorpel MA; Grooteman MP; Nubé MJ; ter Wee PM;
    Semin Dial; 2005; 18(1):47-51. PubMed ID: 15663765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes and consequences of inflammation on anemia management in hemodialysis patients.
    Chawla LS; Krishnan M
    Hemodial Int; 2009 Apr; 13(2):222-34. PubMed ID: 19432697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney disease.
    Kronenberg F
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):729-43. PubMed ID: 15350174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.